相府药业 (837668.OC)

+ 收藏

利润表(相府药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 95,073,654.17226,721,509.3789,179,882.37204,430,652.9391,474,083.41
 营业收入(元) 95,073,654.17226,721,509.3789,179,882.37204,430,652.9391,474,083.41
二、营业总成本(元) 107,796,509.42236,529,964.8099,689,900.60214,313,349.5192,528,042.35
 营业成本(元) 47,733,871.83120,019,303.2956,797,499.97108,976,908.3751,668,295.71
 研发费用(元) 1,736,675.147,517,467.122,122,125.897,223,894.452,114,228.35
 营业税金及附加(元) 1,869,218.343,841,094.541,503,027.743,637,611.601,572,083.94
 销售费用(元) 45,803,274.1078,713,584.9526,534,786.7674,602,003.1028,742,620.30
 管理费用(元) 9,401,633.7723,788,275.6611,398,036.7017,345,649.547,269,584.94
 财务费用(元) 1,251,836.242,650,239.241,334,423.542,527,282.451,161,229.11
  其中:利息费用(元) 1,275,861.102,668,603.751,348,322.222,533,519.381,164,495.51
  其中:利息收入(元) 44,249.1364,132.2436,631.5954,264.0025,859.12
三、其他经营收益
 加:公允价值变动收益(元) 11,464.4226,511.4511,688.9350,660.0528,245.10
 资产处置收益(元) -211.71---
 资产减值损失(元) 1,080,559.88-2,180,519.95-68,923.12-2,140,348.22-166,888.57
 信用减值损失(元) 60,087.64-603,895.81213,491.85-65,655.5035,462.88
 其他收益(元) 329,535.063,489,284.90550,062.721,200,426.40253,339.16
四、营业利润(元) -11,241,208.25-9,076,863.13-9,803,697.85-10,837,613.85-903,800.37
 加:营业外收入(元) 30,526.791,169,202.5646,680.04390,933.27172,068.33
 减:营业外支出(元) 459,206.15164,668.07221,221.60483,500.00143,500.00
五、利润总额(元) -11,669,887.61-8,072,328.64-9,978,239.41-10,930,180.58-875,232.04
 减:所得税费用(元) -1,007,135.96-540,075.07-590,105.69-1,495,996.3453,014.95
六、净利润(元) -10,662,751.65-7,532,253.57-9,388,133.72-9,434,184.24-928,246.99
(一)按经营持续性分类
  持续经营净利润(元) -10,662,751.65-7,532,253.57-9,388,133.72-9,434,184.24-928,246.99
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -10,662,751.65-7,532,253.57-9,388,133.72-9,434,184.24-928,246.99
 扣除非经常性损益后的净利润(元) -10,588,223.75-11,374,714.74-9,717,262.30-10,418,926.00-1,084,343.19
七、每股收益
 一、基本每股收益(元) -0.13-0.09-0.11-0.11-0.01
 二、稀释每股收益(元) -0.13-0.09-0.12-0.11-0.01
九、综合收益总额(元) -10,662,751.65-7,532,253.57-9,388,133.72-9,434,184.24-928,246.99
 归属于母公司所有者的综合收益总额(元) -10,662,751.65-7,532,253.57-9,388,133.72-9,434,184.24-928,246.99
公告日期 2024-08-232024-04-242023-08-242023-04-282022-08-25
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院